Attention AACR Annual Meeting 2018 Registrants – Activate Your Access

Login for full access:

Username and password are not your MyAACR account information

Search:

Search for text in:

separate each search
term with a space

Multiple terms:

Additional Search Filters:

Conference Years:

Days Within Meeting:

Conferences:

Availability:

Participation Type:

Presentations Access:

Presentation Access:

Topic Tracks*:

Organ Site Tracks*:

  • Sort by:
  • Browse by:
<< first | < prev page: of 5 records per page: next > | last >>
pages: 1 2 3 4 5 presentations: 1 to 25 of 123
Overview of thyroid cancer: Epidemiology to state-of art standard of care
Steven I. Sherman
UT MD Anderson Cancer Center, Houston, TX, United States
from AACR Annual Meeting 2018 on April 14, 2018 8:00 AM-10:00 AM
Cancer genomics: Well to poorly differentiated thyroid carcinoma
James A Fagin
Mem. Sloan Kettering Cancer Ctr., New York, NY, United States
from AACR Annual Meeting 2018 on April 14, 2018 8:00 AM-10:00 AM
Discovering targeted therapies of thyroid cancer using drosophila models
Ross L Cagan
Mount Sinai School of Medicine, New York, NY, United States
from AACR Annual Meeting 2018 on April 14, 2018 8:00 AM-10:00 AM
BRAF-targetedtherapy and mechanisms of resistance in thyroid cancer clinical trials
Manisha H Shah
Ohio State Univ. Comp. Cancer Ctr., Columbus, OH, United States
from AACR Annual Meeting 2018 on April 14, 2018 8:00 AM-10:00 AM
Emerging novel RET-Targeted therapy in thyroid cancer
Lori J Wirth
Massachusetts General Hospital, Boston, MA, United States
from AACR Annual Meeting 2018 on April 14, 2018 8:00 AM-10:00 AM
Mechanisms of acquired therapeutic resistance in SCLC
Charles M Rudin
Mem. Sloan Kettering Cancer Ctr., New York, NY, United States
from AACR Annual Meeting 2018 on April 15, 2018 1:00 PM-2:45 PM
Targeting DNA damage response and immune checkpoints in SCLC
Lauren Averett Byers
UT MD Anderson Cancer Ctr., Houston, TX, United States
from AACR Annual Meeting 2018 on April 15, 2018 1:00 PM-2:45 PM
Tumor heterogeneity and therapy response in SCLC
Julien Sage
Stanford Univ. School of Medicine, Stanford, CA, United States
from AACR Annual Meeting 2018 on April 15, 2018 1:00 PM-2:45 PM
Invited Speaker
Yibin Kang
Princeton Univ., Princeton, NJ, United States
from AACR Annual Meeting 2018 on April 16, 2018 7:00 AM-8:00 AM
Chairperson
James A DeCaprio
Dana-Farber Cancer Inst., Boston, MA, United States
from AACR Annual Meeting 2018 on April 16, 2018 1:00 PM-2:45 PM
The genomics and epigenomics of merkel cell carcinoma
Paul W. Harms
University of Michigan, Ann Arbor, MI, United States
from AACR Annual Meeting 2018 on April 16, 2018 1:00 PM-2:45 PM
UV induced mutations and polyomavirus target similar pathways in Merkel cell carcinoma
James A DeCaprio
Dana-Farber Cancer Inst., Boston, MA, United States
from AACR Annual Meeting 2018 on April 16, 2018 1:00 PM-2:45 PM
Immune therapy for Merkel cell carcinoma: Progress and challenges
Paul Nghiem
Univ. of Washington, Seattle, WA, United States
from AACR Annual Meeting 2018 on April 16, 2018 1:00 PM-2:45 PM
Invited Speaker
Joe W Gray
Oregon Health & Science University, Portland, OR, United States
from AACR Annual Meeting 2018 on April 17, 2018 7:00 AM-8:00 AM
Chairperson
Rachel Schiff
Baylor College of Medicine, Houston, TX, United States
from AACR Annual Meeting 2018 on April 17, 2018 1:00 PM-2:45 PM
Endocrine resistance in metastatic breast cancer: Mechanisms and new therapeutic strategies
Rachel Schiff
Baylor College of Medicine, Houston, TX, United States
from AACR Annual Meeting 2018 on April 17, 2018 1:00 PM-2:45 PM
Not all “SERDs” are equal: Context-independent ER degradation and full ER antagonism define the next generation of ER therapeutics
Ciara Metcalfe
Genentech, Inc., South San Francisco, CA, United States
from AACR Annual Meeting 2018 on April 17, 2018 1:00 PM-2:45 PM
Blockade of estrogen signaling boosts antitumor immunity by dwindling cancer-promoting myelopoiesis
Jose R Conejo-Garcia
H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, United States
from AACR Annual Meeting 2018 on April 17, 2018 1:00 PM-2:45 PM
Novel strategies for targeting advanced prostate cancer
Karen E Knudsen
Thomas Jefferson University, Sidney Kimmel Cancer Center, Philadelphia, PA, United States
from AACR Annual Meeting 2018 on April 17, 2018 1:00 PM-2:45 PM
Imaging based readouts in oncology: The pathway to upcoming breakthroughs
Michael V Knopp
Ohio State Univ., Columbus, OH, United States
from AACR Annual Meeting 2018 on April 17, 2018 1:00 PM-2:45 PM
Radiomics and deep learning in breast cancer diagnosis
Maryellen Giger
Univ. of Chicago, Chicago, IL, United States
from AACR Annual Meeting 2018 on April 17, 2018 1:00 PM-2:45 PM
Clinical perspective of radiomics in therapy response monitoring
Lawrence H. Schwartz
Columbia Univ. Medical Ctr., New York, NY, United States
from AACR Annual Meeting 2018 on April 17, 2018 1:00 PM-2:45 PM
Chairperson
Aurora Esquela Kerscher
Eastern Virginia Medical School, Norfolk, VA, United States
from AACR Annual Meeting 2018 on April 17, 2018 3:00 PM-5:00 PM
Small RNA sequencing of preoperative blood plasma identifies microRNA signature enabling to find pancreatic cancer patients who will not benefit from surgical resection
Ondrej Slaby
CEITEC - Central European Institute of Technology, Masaryk University, Brno, Czech Republic
from AACR Annual Meeting 2018 on April 17, 2018 3:00 PM-5:00 PM
MIR1307 mediates pancreatic cancer resistance to FOLFIRINOX chemotherapy by affecting response to DNA damage
Chiara Braconi
The Institute of Cancer Research, London, United Kingdom
from AACR Annual Meeting 2018 on April 17, 2018 3:00 PM-5:00 PM
<< first | < prev page: of 5 records per page: next > | last >>
pages: 1 2 3 4 5 presentations: 1 to 25 of 123